The metabolic clock reveals who will develop dementia decades ahead

A metabolic biomarker in blood plasma identifies individuals at risk of dementia with precision years or decades before symptomatic onset. Among 223,496 UK Biobank participants, those whose predicted metabolic age exceeded chronological age showed 1.61-fold higher dementia risk with earlier disease onset. Analysis identified lipids, lipoproteins, and amino acids as molecular sentries of future cognitive decline. Crucially, this metabolic marker operates along a biological pathway independent from genetic predisposition: individuals with elevated metabolic age delta plus two APOE ε4 alleles exhibited 10.3-fold higher all-cause dementia risk. For clinicians and longevity-focused practitioners, this opens a critical intervention window: while genetic factors remain fixed, the underlying metabolic profile is modifiable through dietary intervention, exercise, and metabolic optimization before neurodegeneration becomes irreversible.